Impact of a high-touch, collaborative, patient-centric, hepatitis C specialty clinical program on completion of glecaprevir/pibrentasvir therapy
Crossref DOI link: https://doi.org/10.1080/21556660.2019.1658325
Published Online: 2019-09-06
Published Print: 2019-09-03
Update policy: https://doi.org/10.1080/tandf_crossmark_01
Swoope, Melissa
Bertram, Carl
Krouskos, Randi
Peeler, Gianna
Wood, Catherine
Version of Record valid from 2019-09-03
Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.
Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ijda20
Publication History
Published: 2019-09-06
